Under- and over-diagnosis of COPD: a global perspective
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Globally, chronic obstructive pulmonary disease (COPD) is the fourth major cause of mortality and morbidity and projected to rise to third within a decade as our efforts to prevent, identify, diagnose and treat patients at a global population level have been insufficient. The European Respiratory Society and American Thoracic Society, along with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document, have highlighted key pathological risk factors and suggested clinical treatment strategies in order to reduce the mortality and morbidity associated with COPD. This review focuses solely on issues related to the under- and over-diagnosis of COPD across the main geographical regions of the world and highlights some of the associated risk factors. Prevalence of COPD obtained mainly from epidemiological studies varies greatly depending on the clinical and spirometric criteria used to diagnose COPD,i.e.forced expiratory volume in 1 s to forced vital capacity ratio <0.7 or 5% below the lower limit of normal, and this subsequently affects the rates of under- and over-diagnosis. Although under-utilisation of spirometry is the major reason, additional factors such as exposure to airborne pollutants, educational level, age of patients and language barriers have been widely identified as other potential risk factors. Co-existent diseases, such as asthma, bronchiectasis, heart failure and previously treated tuberculosis, are reported to be the other determinants of under- and over-diagnosis of COPD. Key points: Globally, there is large variation in the prevalence of COPD, with 10–95% under-diagnosis and 5–60% over-diagnosis (table 1) due to differences in the definition of diagnosis used, and the unavailability of spirometry in rural areas of low- and middle-income countries where the prevalence of COPD is likely to be high. In order to be diagnosed with COPD, patients must have a combination of symptoms with irreversible airflow obstruction defined by a post-bronchodilator FEV 1/FVC ratio of <0.7 or below the fifth centile of the lower limit of normal (LLN), and with a history of significant exposure to a risk factor. Repeat spirometry is recommended if the ratio is between 0.6 and 0.8. Not performing spirometry is the strongest predictor for an incorrect diagnosis of COPD; however, additional factors, such as age, gender, ethnicity, self-perception of symptoms, co-existent asthma, and educational awareness of risk factor by patients and their physician, are also important. COPD can be associated with inhalation of noxious particles other than smoking tobacco. Educational aims: To summarise the global prevalence of over- and under-diagnosis of COPD. To highlight the risk factors associated with the under- and over-diagnosis of COPD. To update readers on the key changes in the recent progress made regarding the correct diagnosis of COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,366
Global burden of COPD: systematic review and meta-analysis
Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00124605 · Cited by 1,499 · cited 2×
“A meta-analysis including North American and European studies reported that under-diagnosis was present in greater than 90% of cases [9].”
BackgroundChronic obstructive pulmonary disease in non-smokers
Salvi, S. S., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61303-9 · Cited by 1,368 · cited 1×
“In a global context, other risk factors, such as exposure to airborne pollutants from household fuel burning, occupation and ambient sources, need to be considered [3, 4].”
BackgroundEisner, M. D., Anthonisen, N., Coultas, D., Kuenzli, N., Perez-Padilla, R., Postma, D., Romieu, I., Silverman, E. K., & Balmes, J. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1757st · Cited by 978 · cited 1×
“In a global context, other risk factors, such as exposure to airborne pollutants from household fuel burning, occupation and ambient sources, need to be considered [3, 4].”
BackgroundPrevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-based Survey
Zhong, N., Wang, C., Yao, W., Chen, P., Kang, J., Huang, S., Chen, B., Wang, C., Ni, D., Zhou, Y., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1749oc · Cited by 729
Mannino, D. M., Gagnon, R. C., Petty, T. L., & Lydick, E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1683 · Cited by 715
Geographic Variations in Prevalence and Underdiagnosis of COPD
Penña, V. S., Miravitlles, M., Gabriel, R., Jiménez-Ruiz, C. A., Villasante, C., Masa, J. F., Viejo, J. L., & Fernández-Fau, L. (2000) · Chest · doi:10.1378/chest.118.4.981 · Cited by 659 · cited 1×
“This occurs often in the setting of advancing age [17, 47], nonsmokers [6], male sex, higher education levels, and symptoms of chronic bronchitis and other comorbidities [47].”
BackgroundPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities
Miravitlles, M., Soriano, J. B., Garcia-Rio, F., Munoz, L., Duran-Tauleria, E., Sanchez, G., Sobradillo, V, & Ancochea, J. (2009) · Thorax · doi:10.1136/thx.2009.115725 · Cited by 640
Swanney, M. P., Ruppel, G., Enright, P. L., Pedersen, O. F., Crapo, R. O., Miller, M. R., Jensen, R. L., Falaschetti, E., Schouten, J. P., Hankinson, J. L., et al. (2008) · Thorax · doi:10.1136/thx.2008.098483 · Cited by 535
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
Fang, L., Gao, P., Bao, H., Tang, X., Wang, B., Feng, Y., Cong, S., Juan, J., Fan, J., Lu, K., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30103-6 · Cited by 467
Interpreting COPD Prevalence Estimates
Halbert, R. J., Isonaka, S., George, D., & Iqbal, A. (2003) · Chest · doi:10.1378/chest.123.5.1684 · Cited by 389
Salvi, S., Kumar, G. A., Dhaliwal, R. S., Paulson, K., Agrawal, A., Koul, P. A., Mahesh, P. A., Nair, S., Singh, V., Aggarwal, A. N., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30409-1 · Cited by 382
Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease
Diab, N., Gershon, A. S., Sin, D. D., Tan, W. C., Bourbeau, J., Boulet, L.-P., & Aaron, S. D. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0621ci · Cited by 324 · cited 1×
“Many studies using the fixed ratio cut-off have reported over-diagnosis of COPD in the elderly and under-diagnosis in younger individuals (<40–45 years), particularly amongst those who are asymptomatic [6, 7].”
BackgroundLifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
Eisner, M. D., Balmes, J., Katz, P. P., Trupin, L., Yelin, E. H., & Blanc, P. D. (2005) · Environmental Health · doi:10.1186/1476-069x-4-7 · Cited by 308
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking
Lindberg, A., Bjerg-Bäcklund, A., Rönmark, E., Larsson, L.-G., & Lundbäck, B. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.04.029 · Cited by 274
Jindal, S. K., Aggarwal, A. N., Gupta, D., Agarwal, R., Kumar, R., Kaur, T., Chaudhry, K., & Shah, B. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0005 · Cited by 270
Hill, K., Goldstein, R. S., Guyatt, G. H., Blouin, M., Tan, W. C., Davis, L. L., Heels-Ansdell, D. M., Erak, M., Bragaglia, P. J., Tamari, I. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091784 · Cited by 262
The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults
COULTAS, D. B., MAPEL, D., GAGNON, R., & LYDICK, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2004029 · Cited by 251
Buist, A. S., Vollmer, W. M., & McBurnie, M. A. (2008) · PubMed · Cited by 246
Burney, P., Jithoo, A., Kato, B., Janson, C., Mannino, D., Niżankowska-Mogilnicka, E., Studnicka, M., Tan, W., Bateman, E., Koçabas, A., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204460 · Cited by 241
Martinez, C. H., Mannino, D. M., Jaimes, F. A., Curtis, J. L., Han, M. K., Hansel, N. N., & Diaz, A. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-388oc · Cited by 214
van Gemert, F., Kirenga, B., Chavannes, N., Kamya, M., Luzige, S., Musinguzi, P., Turyagaruka, J., Jones, R., Tsiligianni, I., Williams, S., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70337-7 · Cited by 205
Jones, R. C. M., Price, D., Ryan, D., Sims, E. J., von Ziegenweidt, J., Mascarenhas, L., Burden, A., Halpin, D. M. G., Winter, R., Hill, S., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70008-6 · Cited by 198
COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican women
Camp, P. G., Ramirez-Venegas, A., Sansores, R. H., Alva, L. F., McDougall, J. E., Sin, D. D., Paré, P. D., Müller, N. L., Silva, C. I. S., Rojas, C. E., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00206112 · Cited by 196 · cited 1×
“These results are consistent with a study of Mexican Mayan women that showed biomass smoke exposure was associated with more air trapping but less emphysema than tobacco smoke exposure [66].”
ResultJindal, S. K., Aggarwal, A. N., Chaudhry, K., Chhabra, S. K., D′Souza, G., Gupta, D. K., Katiyar, S. K., Kumar, R., Shah, B., & Vijayan, V. K. (2006) · PubMed · Cited by 194
Mehta, A. J., Miedinger, D., Keidel, D., Bettschart, R., Bircher, A., Bridevaux, P.-O., Curjuric, I., Kromhout, H., Rochat, T., Rothe, T., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1917oc · Cited by 188 · cited 4×
“Occupational exposure is associated with around 15% of total COPD; however, this has been poorly studied in Central and South America [57, 68, 69].”
BackgroundInfluentialCOPD in the general population: Prevalence, incidence and survival
Afonso, A. S. M., Verhamme, K. M. C., Sturkenboom, M. C. J. M., & Brusselle, G. G. O. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.06.012 · Cited by 180
Çolak, Y., Afzal, S., Nordestgaard, B. G., Vestbo, J., & Lange, P. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30119-4 · Cited by 165
Tilert, T., Dillon, C., Paulose-Ram, R., Hnizdo, E., & Doney, B. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-103 · Cited by 158
Regional COPD Working Group (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00460.x · Cited by 140
The burden and impact of COPD in Asia and Africa.
Chan-Yeung, M. M. W., Ait-Khaled, N., White, N. W., Ip, M., & Tan, W. C. (2004) · PubMed · Cited by 136
COPD Prevalence in Salzburg, Austria
Schirnhofer, L., Lamprecht, B., Vollmer, W. M., Allison, M. J., Studnicka, M., Jensen, R. L., & Buist, A. S. (2007) · CHEST Journal · doi:10.1378/chest.06-0365 · Cited by 136
Prior TB, Smoking, and Airflow Obstruction
Lam, K.-B. H., Jiang, C. Q., Jordan, R., Miller, M. R., Zhang, W. S., Cheng, K. K., Lam, T. H., & Adab, P. (2009) · CHEST Journal · doi:10.1378/chest.09-1435 · Cited by 131
Tuberculosis associated chronic obstructive pulmonary disease
Sarkar, M. S., Srinivasa, Madabhavi, I., & Kumar, K. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12621 · Cited by 126 · cited 1×
“A prior history of tuberculosis was associated with an irreversible AFO irrespective of smoking history, and could result in the over-diagnosis of COPD [59, 60].”
BackgroundFactors associated with misdiagnosis of COPD in primary care
Walters, J. A., Walters, E. H., Nelson, M. R., Robinson, A., Scott, J. L., Turner, P. A., & Wood-Baker, R. R. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00039 · Cited by 120
Aaron, S. D., Tan, W. C., Bourbeau, J., Sin, D. D., Loves, R. H., MacNeil, J. L., & Whitmore, G. A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2531oc · Cited by 110 · cited 1×
“The only predisposing factor for diagnostic reversal was smoking cessation during the 5-year follow-up period [8].”
BackgroundJohnson, P., Balakrishnan, K., Ramaswamy, P., Ghosh, S., Sadhasivam, M., Omprakash, A., Sathiyasekaran, B. W., Smith, K. R., Thanasekaraan, V., & Subhashini, A. S. (2011) · Global Health Action · doi:10.3402/gha.v4i0.7226 · Cited by 104
Meghji, J. Z., Nadeau, G. A., Davis, K. J., Wang, D., Nyirenda, M., Gordon, S. B., & Mortimer, K. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1807oc · Cited by 103
Estimating the prevalence of COPD in Canada: Reported diagnosis versus measured airflow obstruction.
Evans, J., Chen, Y., Camp, P. G., BOWIE, D. M., & McRae, L. (2014) · PubMed · Cited by 100
Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice
Zwar, N. A., Marks, G. B., Hermiz, O. S., Middleton, S., Comino, E. J., Hasan, I., Vagholkar, S., & Wilson, S. F. (2011) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03271.x · Cited by 93
Wood smoke exposure, poverty and impaired lung function in Malawian adults.
Fullerton, D., Suseno, A., Semple, S. E., Kalambo, F., Malamba, R. D., White, S. A., Jack, S., Calverley, P. M., & Gordon, S. B. (2011) · PubMed · Cited by 90
Jaganath, D., Miranda, J. J., Gilman, R. H., Wise, R. A., Diette, G. B., Miele, C. H., Bernabé‐Ortiz, A., Checkley, W., & CRONICAS Cohort Study Group (2015) · Respiratory Research · doi:10.1186/s12931-015-0198-2 · Cited by 90 · cited 1×
“[62] found that in four different areas of Peru, COPD was not fully explained by smoking, and also reported that biomass exposure and tuberculosis were attributable risk factors, particularly in women.”
BackgroundMiravitlles, M., Ferrer, M., Pont, À., Viejo, J. L., Masa, J. F., Gabriel, R., Jimenez-Ruiz, C. A., Villasante, C., Fernández-Fau, L., & Sobradillo, V. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.01.012 · Cited by 88
Nkosi, V., Wichmann, J., & Voyi, K. V. V. (2015) · Environmental Health · doi:10.1186/s12940-015-0018-7 · Cited by 85 · cited 4×
“Occupational exposure is associated with around 15% of total COPD; however, this has been poorly studied in Central and South America [57, 68, 69].”
BackgroundInfluentialHealth Services Burden of Undiagnosed and Overdiagnosed COPD
Gershon, A. S., Thiruchelvam, D., Chapman, K. R., Aaron, S. D., Stanbrook, M. B., Bourbeau, J., Tan, W. C., & To, T. M. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.01.038 · Cited by 84
Quantifying Health Services Use for Chronic Obstructive Pulmonary Disease
Gershon, A. S., Guan, J., Victor, J. C., Goldstein, R. S., & To, T. M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2044oc · Cited by 82
Danielsson, P., Ólafsdóttir, I. S., Benediktsdóttir, B., Gíslason, Þ., & Janson, C. (2011) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2011.00257.x · Cited by 82
Chronic Obstructive Pulmonary Disease in Finland: Prevalence and Risk Factors
Kotaniemi, J., Sovijärvi, A. R. A., & Lundbäck, B. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550500218122 · Cited by 76
The prevalence of asthma and COPD in Italy: A practice-based study
Cazzola, M., Puxeddu, E., Bettoncelli, G., Novelli, L., Segreti, A., Cricelli, C. A., & Calzetta, L. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.022 · Cited by 75
Subdiagnóstico de DPOC na atenção primária em Aparecida de Goiânia, Goiás
de Queiroz, M. C. D. C. A. M., Moreira, M. A. C., & Rabahi, M. F. (2012) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132012000600003 · Cited by 75
Prevalence of COPD in Copenhagen
Fabricius, P. G., Løkke, A., Marott, J. L., Vestbo, J., & Lange, P. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.019 · Cited by 68
Xu, F., Yin, X.-M., Zhang, M., Shen, H., Lu, L., & Xu, Y. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2818 · Cited by 66
Chronic Airflow Obstruction in a Black African Population: Results of BOLD Study, Ile-Ife, Nigeria
Obaseki, D., Erhabor, G. E., Gnatiuc, L., Adewole, O., Buist, S. A., & Burney, P. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1041102 · Cited by 66 · cited 1×
“7% in Ile-Ife in a Nigerian population aged 40 years and over [51] although only 0.”
BackgroundHvidsten, S. C., Storesund, L., Wentzel‐Larsen, T., Gulsvik, A., & Lehmann, S. (2009) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2009.00137.x · Cited by 66
van Gemert, F. A., Chavannes, N. H., Nabadda, N., Luzige, S., Kirenga, B., Eggermont, C. J., de Jong, C., & van der Molen, T. (2013) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2013.00064 · Cited by 66
Ngahane, B. H. M., Ze, E. A., Chebu, C., Mapoure, N. Y., Temfack, E., Nganda, M., & Luma, N. H. (2014) · International Journal of Occupational and Environmental Health · doi:10.1179/2049396714y.0000000090 · Cited by 60
Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in Bangladesh.
Alam, D. S., Chowdhury, M. A. H., Siddiquee, A. T., Ahmed, S., & Clemens, J. D. (2015) · PubMed · doi:10.3109/15412555.2015.1041101 · Cited by 52
Pefura-Yone, E. W., Fodjeu, G., Kengne, A. P., Roche, N., & Kuaban, C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.12.003 · Cited by 52 · cited 1×
“2% (24/461) in HIV-positive participants and 5% (23/461) in HIV-negative participants, with no statistical correlation between HIV status and increased prevalence of COPD [58].”
BackgroundCollins, B. F., Ramenofsky, D. H., Au, D. H., Ma, J., Uman, J. E., & Feemster, L. C. (2014) · CHEST Journal · doi:10.1378/chest.13-2759 · Cited by 46
Melbye, H., Drivenes, Dalbak, Leinan, Ostrem, & Hoegh-Henrichsen (2011) · International Journal of COPD · doi:10.2147/copd.s25955 · Cited by 42
Fan, W., Lee, H., Lee, A., Kieu, C., & Wong, N. D. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.08.001 · Cited by 41
Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China
Lu, M., Yao, W.-Z., Zhong, N., Zhou, Y., Wang, C., Chen, P., Kang, J., Huang, S., Chen, B.-Y., Wang, C., et al. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01817.x · Cited by 36 · cited 1×
“physician and thus are usually under-diagnosed [72].”
Prieto-Centurion, V., Huang, F. F.-Y., Naureckas, E. T., Camargo, C. A., Charbeneau, J., Joo, M. J., Press, V. G., & Krishnan, J. A. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-73 · Cited by 33 · cited 1×
“Over-diagnosis is also more common in the setting of elevated body mass index [44, 48] and having an older primary care provider [6].”
BackgroundOver diagnosis of chronic obstructive pulmonary disease in an underserved patient population
Ghattas, C., Dai, Gemmel, D. J., & Awad (2013) · International Journal of COPD · doi:10.2147/copd.s45693 · Cited by 31
Miele, C. H., Jaganath, D., Miranda, J. J., Bernabé‐Ortiz, A., Gilman, R. H., Johnson, C. M., Diette, G. B., Wise, R. A., Checkley, W., & The CRONICAS Cohort Study Group (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1067765 · Cited by 26
Kurmi, O., Li, L., Smith, M. C., Augustyn, M., Chen, J., Collins, R., Yu, C., Han, Y., Qin, J., Xu, G., et al. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2014-000025 · Cited by 25
Self-citationArshukova, I. L., Artyukhov, I. P., Shulmin, A. V., Dobretsova, E., Dugina, T., & Демко, И. В. (2015) · International Journal of COPD · doi:10.2147/copd.s79601 · Cited by 24
Prevalence of chronic bronchitis in an industrial population in North India.
Joshi, R. C., Madan, R. N., & Brash, A. A. (1975) · Thorax · doi:10.1136/thx.30.1.61 · Cited by 17
Metadata
- Authors
- Ho, T., Cusack, R. P., Chaudhary, N., Satia, I., & Kurmi, O. P.
- Venue
- Breathe
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-03
- Volume
- 15
- Issue
- 1
- Pages
- 24-35
- ISSN
- 1810-6838 (ISSN-L)
- 2073-4735
- OpenAlex
- W2918961688
- Cited by
- 207
- References
- 70
- FWCI
- 15.32
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.